How to Test Human-Specific Combination Immunotherapies In Vivo

Learn how to evaluate combinations of human-specific checkpoint inhibitors in vivo, with double knock-in humanized drug target mouse models.

CRISPR Clinical Trials: A 2021 Update - Innovative Genomics Institute (IGI)

Cancers, Free Full-Text

Nanotechnology-based products for cancer immunotherapy

Catecholamines Induce Trained Immunity in Monocytes In Vitro and In Vivo

Multi-color nanoprobes for biomarker-specific in vivo imaging. a

Cell-penetrating peptides enhance peptide vaccine accumulation and persistence in lymph nodes to drive immunogenicity

Combined disruption of T cell inflammatory regulators Regnase-1 and Roquin-1 enhances antitumor activity of engineered human T cells

The next wave of cellular immunotherapies in pancreatic cancer - ScienceDirect

Frontiers Recent Progress on Immunotherapy for Breast Cancer: Tumor Microenvironment, Nanotechnology and More

In Vitro T Cell Killing Assay Protocol Using Millicell® Microwell Plates

Antibody–drug conjugates: in search of partners of choice: Trends in Cancer

In vivo CD8+ T cell CRISPR screening reveals control by Fli1 in infection and cancer - ScienceDirect

IJMS, Free Full-Text

Targeting Tumor-Associated Antigens and Tumor-Specific Antigens

Frontiers Humanized Mice as a Valuable Pre-Clinical Model for Cancer Immunotherapy Research